Prospective investigation of positron emission tomography in lung nodules

Val J. Lowe, James Fletcher, Lisa Gobar, Michael Lawson, Peter Kirchner, Peter Valk, John Karis, Karl Hubner, Dominique Delbeke, Elizabeth V. Heiberg, Edward F. Patz, R. Edward Coleman

Research output: Contribution to journalArticle

476 Citations (Scopus)

Abstract

Purpose: Solitary pulmonary nodules (SPNs) are commonly identified chest radiographs and computed tomography (CT). Biopsies are often performed to evaluate the nodules further. An accurate, noninvasive diagnostic test could avoid the morbidity and costs of invasive tissue sampling. We evaluated the ability of fluorine-18 deoxyglucose positron emission tomography (FDG-PET) to discriminate between benign and malignant pulmonary nodules in a prospective, multicenter trial. Methods: Eighty-nine patients who had newly identified indeterminate SPNs on chest radiographs and CT were evaluated with FDG-PET. PET data were analyzed semiquantitatively calculating standardized uptake values (SUVs) as on index of FDG accumulation and also o visual scoring method. PET results were compared with pathology results. Results: Sixty SPNs were malignant and 29 were benign. Using SUV data, PET had an overall sensitivity and specificity for detection of malignant nodules of 92% and 90%. Visual analysis provided o slightly higher, but not statistically significant, sensitivity of 98% and lower specificity of 69%. For SPNs ≤ 1.5 cm (34 of 89), the sensitivity and specificity of SUV and visual analysis were 80% and 95% and 100% and 74%, respectively. Conclusion: FDG-PET can accurately characterize indeterminate SPNs. PET imaging provides o noninvasive method to evaluate indeterminate SPNs, which can reduce the need for invasive tissue biopsy.

Original languageEnglish (US)
Pages (from-to)1075-1084
Number of pages10
JournalJournal of Clinical Oncology
Volume16
Issue number3
StatePublished - Mar 1998
Externally publishedYes

Fingerprint

Solitary Pulmonary Nodule
Positron-Emission Tomography
Lung
Fluorine
Deoxyglucose
Thorax
Tomography
Biopsy
Sensitivity and Specificity
Routine Diagnostic Tests
Multicenter Studies
Research Design
Pathology
Morbidity
Costs and Cost Analysis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lowe, V. J., Fletcher, J., Gobar, L., Lawson, M., Kirchner, P., Valk, P., ... Coleman, R. E. (1998). Prospective investigation of positron emission tomography in lung nodules. Journal of Clinical Oncology, 16(3), 1075-1084.

Prospective investigation of positron emission tomography in lung nodules. / Lowe, Val J.; Fletcher, James; Gobar, Lisa; Lawson, Michael; Kirchner, Peter; Valk, Peter; Karis, John; Hubner, Karl; Delbeke, Dominique; Heiberg, Elizabeth V.; Patz, Edward F.; Coleman, R. Edward.

In: Journal of Clinical Oncology, Vol. 16, No. 3, 03.1998, p. 1075-1084.

Research output: Contribution to journalArticle

Lowe, VJ, Fletcher, J, Gobar, L, Lawson, M, Kirchner, P, Valk, P, Karis, J, Hubner, K, Delbeke, D, Heiberg, EV, Patz, EF & Coleman, RE 1998, 'Prospective investigation of positron emission tomography in lung nodules', Journal of Clinical Oncology, vol. 16, no. 3, pp. 1075-1084.
Lowe VJ, Fletcher J, Gobar L, Lawson M, Kirchner P, Valk P et al. Prospective investigation of positron emission tomography in lung nodules. Journal of Clinical Oncology. 1998 Mar;16(3):1075-1084.
Lowe, Val J. ; Fletcher, James ; Gobar, Lisa ; Lawson, Michael ; Kirchner, Peter ; Valk, Peter ; Karis, John ; Hubner, Karl ; Delbeke, Dominique ; Heiberg, Elizabeth V. ; Patz, Edward F. ; Coleman, R. Edward. / Prospective investigation of positron emission tomography in lung nodules. In: Journal of Clinical Oncology. 1998 ; Vol. 16, No. 3. pp. 1075-1084.
@article{91258b693752459ca6b8b27300c4c4d8,
title = "Prospective investigation of positron emission tomography in lung nodules",
abstract = "Purpose: Solitary pulmonary nodules (SPNs) are commonly identified chest radiographs and computed tomography (CT). Biopsies are often performed to evaluate the nodules further. An accurate, noninvasive diagnostic test could avoid the morbidity and costs of invasive tissue sampling. We evaluated the ability of fluorine-18 deoxyglucose positron emission tomography (FDG-PET) to discriminate between benign and malignant pulmonary nodules in a prospective, multicenter trial. Methods: Eighty-nine patients who had newly identified indeterminate SPNs on chest radiographs and CT were evaluated with FDG-PET. PET data were analyzed semiquantitatively calculating standardized uptake values (SUVs) as on index of FDG accumulation and also o visual scoring method. PET results were compared with pathology results. Results: Sixty SPNs were malignant and 29 were benign. Using SUV data, PET had an overall sensitivity and specificity for detection of malignant nodules of 92{\%} and 90{\%}. Visual analysis provided o slightly higher, but not statistically significant, sensitivity of 98{\%} and lower specificity of 69{\%}. For SPNs ≤ 1.5 cm (34 of 89), the sensitivity and specificity of SUV and visual analysis were 80{\%} and 95{\%} and 100{\%} and 74{\%}, respectively. Conclusion: FDG-PET can accurately characterize indeterminate SPNs. PET imaging provides o noninvasive method to evaluate indeterminate SPNs, which can reduce the need for invasive tissue biopsy.",
author = "Lowe, {Val J.} and James Fletcher and Lisa Gobar and Michael Lawson and Peter Kirchner and Peter Valk and John Karis and Karl Hubner and Dominique Delbeke and Heiberg, {Elizabeth V.} and Patz, {Edward F.} and Coleman, {R. Edward}",
year = "1998",
month = "3",
language = "English (US)",
volume = "16",
pages = "1075--1084",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",

}

TY - JOUR

T1 - Prospective investigation of positron emission tomography in lung nodules

AU - Lowe, Val J.

AU - Fletcher, James

AU - Gobar, Lisa

AU - Lawson, Michael

AU - Kirchner, Peter

AU - Valk, Peter

AU - Karis, John

AU - Hubner, Karl

AU - Delbeke, Dominique

AU - Heiberg, Elizabeth V.

AU - Patz, Edward F.

AU - Coleman, R. Edward

PY - 1998/3

Y1 - 1998/3

N2 - Purpose: Solitary pulmonary nodules (SPNs) are commonly identified chest radiographs and computed tomography (CT). Biopsies are often performed to evaluate the nodules further. An accurate, noninvasive diagnostic test could avoid the morbidity and costs of invasive tissue sampling. We evaluated the ability of fluorine-18 deoxyglucose positron emission tomography (FDG-PET) to discriminate between benign and malignant pulmonary nodules in a prospective, multicenter trial. Methods: Eighty-nine patients who had newly identified indeterminate SPNs on chest radiographs and CT were evaluated with FDG-PET. PET data were analyzed semiquantitatively calculating standardized uptake values (SUVs) as on index of FDG accumulation and also o visual scoring method. PET results were compared with pathology results. Results: Sixty SPNs were malignant and 29 were benign. Using SUV data, PET had an overall sensitivity and specificity for detection of malignant nodules of 92% and 90%. Visual analysis provided o slightly higher, but not statistically significant, sensitivity of 98% and lower specificity of 69%. For SPNs ≤ 1.5 cm (34 of 89), the sensitivity and specificity of SUV and visual analysis were 80% and 95% and 100% and 74%, respectively. Conclusion: FDG-PET can accurately characterize indeterminate SPNs. PET imaging provides o noninvasive method to evaluate indeterminate SPNs, which can reduce the need for invasive tissue biopsy.

AB - Purpose: Solitary pulmonary nodules (SPNs) are commonly identified chest radiographs and computed tomography (CT). Biopsies are often performed to evaluate the nodules further. An accurate, noninvasive diagnostic test could avoid the morbidity and costs of invasive tissue sampling. We evaluated the ability of fluorine-18 deoxyglucose positron emission tomography (FDG-PET) to discriminate between benign and malignant pulmonary nodules in a prospective, multicenter trial. Methods: Eighty-nine patients who had newly identified indeterminate SPNs on chest radiographs and CT were evaluated with FDG-PET. PET data were analyzed semiquantitatively calculating standardized uptake values (SUVs) as on index of FDG accumulation and also o visual scoring method. PET results were compared with pathology results. Results: Sixty SPNs were malignant and 29 were benign. Using SUV data, PET had an overall sensitivity and specificity for detection of malignant nodules of 92% and 90%. Visual analysis provided o slightly higher, but not statistically significant, sensitivity of 98% and lower specificity of 69%. For SPNs ≤ 1.5 cm (34 of 89), the sensitivity and specificity of SUV and visual analysis were 80% and 95% and 100% and 74%, respectively. Conclusion: FDG-PET can accurately characterize indeterminate SPNs. PET imaging provides o noninvasive method to evaluate indeterminate SPNs, which can reduce the need for invasive tissue biopsy.

UR - http://www.scopus.com/inward/record.url?scp=0031935402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031935402&partnerID=8YFLogxK

M3 - Article

C2 - 9508193

AN - SCOPUS:0031935402

VL - 16

SP - 1075

EP - 1084

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -